Neurovascular-immune mediator dynamics in migraine: State-dependent effects of caffeine
Abstract
Background: Migraine is a complex neurovascular disorder involving interactions between trigeminovascular, endothelial, and neuroimmune pathways. Dysregulation of key mediators-calcitonin gene-related peptide (CGRP), nitric oxide (NO), endothelin-1, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α)-is central to its pathophysiology. However, their phase-dependent dynamics and acute responsiveness to caffeine remain unclear. This study evaluated phase-specific alterations in these mediators and their intra-individual response to caffeine.
Methods: A total of 327 participants (174 migraine patients and 153 healthy controls) were included. Migraine patients were assessed across interictal and ictal phases using a within-subject design. During ictal attacks, participants underwent a randomized, double-blind, placebo-controlled crossover intervention with 200 mg caffeine or placebo. Blood samples were collected at baseline (T0) and 60 min post-intervention (T1). Mediators were measured using ELISA and analyzed with linear mixed-effects models.
Results: CGRP, NO, IL-6, and TNF-α were significantly elevated during migraine, particularly in the ictal phase, while endothelin-1 was reduced. Caffeine significantly decreased CGRP and NO levels and increased endothelin-1 compared with placebo. IL-6 and TNF-α showed modest reductions. Responses varied between individuals, with greater effects observed in those with higher baseline levels.
Conclusions: Migraine is characterized…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 327 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.